over active bladder. Overactive bladder
Conditions
Interventions
Intervention 1: Intervention group: Women with acidic urine and hyperactive bladder symptoms over 18 years of age who are randomly selected and treated with sodium bicarbonate 500 twice a day by 36 pa
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Patients referred to the gynecology clinic included all patients over 18 years of age who voluntarily and knowingly complained of overactive bladder symptoms who had these symptoms for at least 12 weeks and received no treatment, had a frequency of more than 8 times and more than 2 times nocturia, urinary pH less than 6 and lacked of relaxation. Patients under 18 years of age, urinary pH more than 6, kidney stones, stress incontinence, history of abdominal menopause surgery, heart problems, urinary tract infections, malignancies, pelvic pain, neurogenic bladder , Use of antidepressants, anticholinergics, alphablockers, beta-3 agonists, and history of allergies to anticholinergics, sodium bicarbonate, rectocell, cystocell, and uterine prolapse, frequency Less than 8 and nocturia less than 2 in 24 hours are not included in the study.
Exclusion criteria
Exclusion criteria: If the patient does not want to continue taking. Allergic reaction to the drug. The patient becomes pregnant. Reluctance to continue cooperation in the project. They are excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| OVER ACTIVE BLADDER SCORE POINT. Timepoint: One month after taking the drug. Method of measurement: questionnaire OAB-V8.;URINE PH. Timepoint: Before administration of tolterodine and sodium bicarbonate at the beginning of the study and one month after receiving tolterodine and sodium bicarbonate. Method of measurement: urine dipstick.;Oab-v8 questionnaire score based on score before and after receiving tolterodine and sodium bicarbonate. Timepoint: Before administration of tolterodine and sodium bicarbonate at the beginning of the study and one month after receiving tolterodine and sodium bicarbonate. Method of measurement: Scoring based on the score of the questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactTayebeh Jahed Bozorgan
Shahid Beheshti University of Medical Sciences
Outcome results
None listed